forwardvuepharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: | ||
Meta Tags
| Title | ForwardVue |
| Description | Motivated to improve the treatment burden of patients with retinal Home About Contact More Home About Contact Home About Contact Motivated to improve the treatment burden of patients with retinal diseases Novel VEGF-indep |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.71.232.3 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
forwardvuepharma.com Valuation
|
US$429,167
Last updated: 2023-04-29 00:17:36
forwardvuepharma.com has Semrush global rank of 24,662,487. forwardvuepharma.com has an estimated worth of US$ 429,167, based on its estimated Ads revenue. forwardvuepharma.com receives approximately 49,520 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, forwardvuepharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$429,167 |
| Daily Ads Revenue | US$397 |
| Monthly Ads Revenue | US$11,885 |
| Yearly Ads Revenue | US$142,616 |
| Daily Unique Visitors | 3,302 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| forwardvuepharma.com. | A | 599 | IP: 198.71.232.3 |
| forwardvuepharma.com. | NS | 3600 | NS Record: ns16.domaincontrol.com. |
| forwardvuepharma.com. | NS | 3600 | NS Record: ns15.domaincontrol.com. |
| forwardvuepharma.com. | MX | 3600 | MX Record: 0 forwardvuepharma-com.mail.protection.outlook.com. |
| forwardvuepharma.com. | TXT | 3600 | TXT Record: NETORGFT5904324.onmicrosoft.com |
| forwardvuepharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-04-29 00:17:36
| Home About Contact More Home About Contact Home About Contact Motivated to improve the treatment burden of patients with retinal diseases Novel VEGF-independent drug delivery platform Novel long acting orai1 blocker Pre-clinical, patent protected Our lead molecule is a novel long acting ORAI1 blocker that acts both upstream and downstream of VEGF inhibition for durable administration up to 12 months to treat retinal neovascular disease. Target dosing will be 1-2 intravitreal injections per year. Alan J. Franklin MD, PhD Ophthalmologist, Vitreoretinal Diseases and Surgery Dr. Alan Franklin attended Northwestern University as an undergraduate where he obtained a Bachelor of Science in Biomedical Engineering then attended medical school at the Medical College of Ohio/ University of Toledo. After graduating medical school, Dr. Franklin earned a PhD at Vanderbilt University in the Department of Molecular Physiology and Biophysics. His thesis focused upon the molecular biology and cell type |
HTTP Headers
HTTP/1.1 301 Moved Permanently location: https://forwardvuepharma.com/ Vary: Accept-Encoding Server: DPS/1.11.8 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Thu, 21 Oct 2021 22:14:22 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.11.8 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Thu, 21 Oct 2021 22:14:22 GMT |
forwardvuepharma.com Whois Information
Domain Name: FORWARDVUEPHARMA.COM Registry Domain ID: 2469002303_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-12-19T01:42:28Z Creation Date: 2019-12-19T01:42:27Z Registry Expiry Date: 2021-12-19T01:42:27Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS15.DOMAINCONTROL.COM Name Server: NS16.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T17:06:30Z <<< |